MSB 0.91% $1.11 mesoblast limited

Ann: Remestemcel-L for COPD Published in Respiratory Research, page-67

  1. 11,087 Posts.
    lightbulb Created with Sketch. 694
    In the same time you have 1 patient in a trial.......
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.